fomesafen has been researched along with Autosomal Dominant Myotubular Myopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beggs, AH; Brezovec, AG; Buj-Bello, A; Buscara, L; Childers, MK; Denard, J; Elverman, MR; Goddard, MA; Gopal, N; Grange, RW; Hogrel, JY; Kelly, VE; Latournerie, V; Lawlor, MW; Le Bec, C; Liu, F; Mack, DL; Mavilio, F; Meng, H; Mingozzi, F; O'Callaghan, M; Poulard, K; Smith, BK; Snyder, JM; Strande, JL; Veron, P; Yang, L | 1 |
1 other study(ies) available for fomesafen and Autosomal Dominant Myotubular Myopathy
| Article | Year |
|---|---|
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
Topics: Animals; Biopsy; Dependovirus; Disease Models, Animal; Disease Progression; Dogs; Gait; Gene Expression; Genetic Therapy; Genetic Vectors; Immunity, Cellular; Immunity, Humoral; Kaplan-Meier Estimate; Muscle Strength; Muscle, Skeletal; Myopathies, Structural, Congenital; Protein Tyrosine Phosphatases, Non-Receptor; Recovery of Function; Reflex; Respiratory Function Tests; Tissue Distribution; Transgenes; Treatment Outcome | 2017 |